Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-008982
Filing Date
2010-02-19
Accepted
2010-02-19 12:37:37
Documents
14
Period of Report
2009-10-31

Document Format Files

Seq Description Document Type Size
1 v174517_10k.htm 10-K 2601174
2 GRAPHIC chart1.jpg GRAPHIC 78873
3 GRAPHIC chart2.jpg GRAPHIC 71891
4 GRAPHIC chart3.jpg GRAPHIC 75816
5 GRAPHIC chart4.jpg GRAPHIC 61186
6 GRAPHIC chart5.jpg GRAPHIC 51107
7 GRAPHIC chart6.jpg GRAPHIC 71663
8 v174517_ex4-17.htm EX-4.17 25964
9 v174517_ex10-62.htm EX-10.62 85677
10 v174517_ex23-1.htm EX-23.1 4701
11 v174517_ex31-1.htm EX-31.1 17266
12 v174517_ex31-2.htm EX-31.2 17045
13 v174517_ex32-1.htm EX-32.1 6408
14 v174517_ex32-2.htm EX-32.2 7779
  Complete submission text file 0001144204-10-008982.txt   3334029
Mailing Address TECHNOLOGY CENTRE OF NEW JERSEY 675 ROUTE 1 NORTH BRUNSWICK NJ 08902
Business Address TECHNOLOGY CENTRE OF NEW JERSEY 675 ROUTE 1 NORTH BRUNSWICK NJ 08902 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

EIN.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 000-28489 | Film No.: 10618830
SIC: 2834 Pharmaceutical Preparations